2019
DOI: 10.1016/j.xphs.2018.09.023
|View full text |Cite
|
Sign up to set email alerts
|

1H NMR Relaxation Study to Evaluate the Crystalline State of Active Pharmaceutical Ingredients Containing Solid Dosage Forms Using Time Domain NMR

Abstract: The aim of this study was to demonstrate the usefulness of the time domain nuclear magnetic resonance (TD-NMR) method to characterize the crystalline state of active pharmaceutical ingredients (APIs) containing solid dosage forms. In this study, carbamazepine and indomethacin are used as models for poorly water-soluble APIs. First, we measured the T 1 and T 2 relaxation behavior of crystalline and amorphous APIs. From the results, we were able to confirm that the T 1 relaxation time measured by TD-NMR is an ef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
26
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 32 publications
(29 citation statements)
references
References 33 publications
2
26
0
1
Order By: Relevance
“…One can suppose that it is related to the reconstruction of the bifurcated hydrogen bond network in crystalline sample. 14 Bi-exponential recovery of magnetization was previously observed in cyclodextrin with diazepam, 48 drugs in silica matrices, [49][50][51] drugs with polymers, 23,52 or in the process of recrystallization of FLD of different grain sizes 42 of amorphous API. 53 The measurement 14 weeks aer amorphization showed a one-exponential magnetization recovery in all temperature range.…”
Section: The Kinetics Of Recrystallizationmentioning
confidence: 86%
“…One can suppose that it is related to the reconstruction of the bifurcated hydrogen bond network in crystalline sample. 14 Bi-exponential recovery of magnetization was previously observed in cyclodextrin with diazepam, 48 drugs in silica matrices, [49][50][51] drugs with polymers, 23,52 or in the process of recrystallization of FLD of different grain sizes 42 of amorphous API. 53 The measurement 14 weeks aer amorphization showed a one-exponential magnetization recovery in all temperature range.…”
Section: The Kinetics Of Recrystallizationmentioning
confidence: 86%
“…Various technical approaches have been applied in the pharmaceutical industry to improve the solubility of active pharmaceutical ingredients (APIs). [1][2][3][4][5] Amorphization using the solid dispersion (SD) technique is regarded as a promising pharmaceutical technology. 5) We recently used the timedomain NMR (TD-NMR) method to evaluate the crystalline state of APIs incorporated into solid oral dosage forms including amorphous SDs.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4][5] Amorphization using the solid dispersion (SD) technique is regarded as a promising pharmaceutical technology. 5) We recently used the timedomain NMR (TD-NMR) method to evaluate the crystalline state of APIs incorporated into solid oral dosage forms including amorphous SDs. 6,7) TD-NMR is a benchtop instrument used for measuring the 1 H-NMR relaxation.…”
Section: Introductionmentioning
confidence: 99%
“…For the development of solid-dispersion formulations, maintaining the amorphous state throughout the shelflife period is still a huge challenge. 11) Thus, it is important to investigate the crystalline state of APIs in solid dispersions in more detail.…”
Section: Introductionmentioning
confidence: 99%